Manufacturing Facilities
Home > Business Development > Manufacturing Facilities
The wide offer of high-quality product enables Hanmi to reach favorable business results. To keep this trend in the future, Hanmi has recently completed two plants investing USD 93 million in order to implement new technological upgrades and to constantly supply good qualified products. Hanmi is planning to takeoff as a Global Pharmaceutical Company with newly built plants since they achieved as no.1 in the Korean market and is currently looking for partners to collaborate in the field of Contract Manufacturing for innovative drug APIs, key intermediates, Cephalosporin APIs, finished products, and both oral and injectables. In order to review Hanmi’s plants please follow the instructions for our newly built plants, which will bring you successful and excellent Contract Manufacturing Service.
Hanmi Cepha Plant is the plant for the production of Cephalosporine finished dosage dedicated to both oral solid and powder parenteral injections. Its capacity will be about 30 million powder injections per year and the capacity for other oral Cephalosporine products like tablet, capsule and dry syrup is also enough.
Further to this, Hanmi plans to set up additional lines in this facility for future expansion and for the satisfaction of customer’s needs.The total surface of the new plant, which is a three-storied building, covers 9,758 m2, of which almost 60% are the production premises. The production process is fully automated.

| Floor | Area size (㎡) | Floor Activities |
|---|---|---|
| 3rd | 2,820 | Oral solid area, QC laboratories |
| 2nd | 995 | QA Office, Control room, GMP library, gowning area for packaging |
| 1st | 3,030 | Parenteral area, General office, Material receiving and shippping |
| B1 | 2,913 | HVAC, Water Treatment system, Engineering Room |
| Sum | 9,758 |
Powder Parenteral Drug
Oral Dry Product

45 Bangi-dong. Songpa. Seoul 138-724 Korea Tel 82. 2. 410. 9114
Copyright (c) 2004 by Hanmi Pham Co Ltd. All rights reserved